Microgestin Fe 1.5/30 NDC 75907-081

NDC codes

FDA NDC Directory

Product NDC (as listed)75907-081Labeler and product segments. Claims need a package NDC.

Product NDC at billing width75907-0081Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
75907-081-28	75907008128	1 BLISTER PACK in 1 PACKET (75907-081-28) / 1 KIT in 1 BLISTER PACKMarketed from May 1, 2024
75907-081-62	75907008162	6 BLISTER PACK in 1 CARTON (75907-081-62) / 1 KIT in 1 BLISTER PACKMarketed from May 1, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Microgestin Fe 1.5/30
Generic name (nonproprietary): norethindrone acetate/ethinyl estradiol and ferrous fumarate
Dosage form: Kit
Labeler: Dr. Reddys Laboratories Inc
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091453
Marketing start: May 1, 2024
Listing expires: Dec 31, 2026
Identifiers: Product ID 75907-081_d99091ee-4bfb-4232-9e4e-acdc153b04aeSPL ID d99091ee-4bfb-4232-9e4e-acdc153b04aeSPL set ID 17b4ee33-3ec1-440d-9446-f20c51629c2dRxCUI 259176, 1359022, 1359023, 1359027

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N475907008128 followed by a unit qualifier and the quantity

Package 75907-0081-28. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 16, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Microgestin Fe 1.5/30 is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. Oral contraceptives are highly effective. Table I lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. The efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. Correct and consistent use of methods can result in lower failure rates. table1

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 091453

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 091453
Product	Strength	Form · route	Labeler	Product NDC
Microgestin Fe 1.5/30norethindrone acetate/ethinyl estradiol and ferrous fumarate	—	Kit	Proficient Rx LP	82804-096
Larin Fe 1.5/30norethindrone acetate/ethinyl estradiol and ferrous fumarate	—	Kit	Northstar Rx LLC	16714-405
Microgestin Fe 1.5/30norethindrone acetate/ethinyl estradiol and ferrous fumarate	—	Kit	Mayne Pharma Inc.	51862-870